NASDAQ:LMAT   LeMaitre Vascular, Inc.
Sales grew 9% to $28.4 million. That was well ahead of the $25.9 million that analysts had projected.
Operating income surged 14% to $7.2 million.
Net income grew 41% to $6 million, or $0.30 per share. That figure blew past the $0.20 that Wall Street was expecting.
The board of directors approved a 21% increase to the quarterly dividend and gave the thumbs-up to repurchasing $10 million shares of common stock.
Zooming out to the full year, here's how the company performed in 2018:

Revenue jumped 5% to $105.6 million. That was solidly ahead of the $103 million that was expected.
Net income grew 34% to $22.9 million. However, the bulk of the increase is attributable to one-time gains on business divestitures and acquisitions.
EPS jumped 31% to $1.13. This was comfortably above the $1.04 that market watchers were expecting.

finance.yahoo.c...-161800004.html?.tsrc=rss


免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。